The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids

Ann Hepatol. 2022 Jul-Aug;27(4):100704. doi: 10.1016/j.aohep.2022.100704. Epub 2022 Apr 6.

Authors

Somayeh Shokri¹, Shahab Mahmoudvand²

Affiliations

¹ Department of Virology, School of Medicine, Hamadan University of Medical Science, Hamadan, Iran.
² Department of Virology, School of Medicine, Hamadan University of Medical Science, Hamadan, Iran. Electronic address: mahmoudvandsh100@yahoo.com.

No abstract available

Publication types

Letter

MeSH terms

Adrenal Cortex Hormones / adverse effects
Antiviral Agents / adverse effects
COVID-19*
Hepacivirus / genetics
Hepatitis B Surface Antigens
Hepatitis B virus / physiology
Hepatitis C* / diagnosis
Hepatitis C* / drug therapy
Hepatitis C* / epidemiology
Humans
Virus Activation

Substances

Adrenal Cortex Hormones
Antiviral Agents
Hepatitis B Surface Antigens